onewayticket
05 Apr 2017
Re: Toplisted 2 sell flags in 2 days Ewan and a share price that's gone upward about 70% against your recommendation and by the looks of the volume still more to go. I must add you to my favourites.There's clearly something going on here. Everyone's guess as good as the others. I'm going for a decent non-core asset sale being agreed. Complete guess on my part.Expect similar and more with Darwin gone.Own due diligence.
Ewan Hoosami
05 Apr 2017
Re: Toplisted Strange that yesterday's graphene story was about a research breakthrough in desalination.This from the interims:Water Treatment· Within the Water Treatment offerings the Group is able to source, treat and distribute water in a cost effective manner. Current focus sectors are clean drinking water, desalination, processed & produced water, and sewage & waste water treatment---------- ---------- ---------- ------Apparently GRPH seems to be offering desalination already.
onewayticket
05 Apr 2017
Volume Noticeably up today.What's brewing or what's leaked.Own due diligence
onewayticket
05 Apr 2017
Re: Toplisted For the time being you called it wrong.Just be graceful. Some on here may be silent holders in stock that you own elsewhereGrph was in well oversold territory. Sorry you missed the rebound.Yes graphene seems to be flavour again.Own due diligence.
Ewan Hoosami
04 Apr 2017
Re: Toplisted Maybe the media buzz around graphene today will give shareholders some brief respite.Oversold doesn't mean undervalued - be careful out there.
onewayticket
04 Apr 2017
Toplisted Number 1 for today[link] around so not getting overexcited but it'll probably do the same when they clear or GRPH gains the ability to buy itself out of the CULN agreement.Sour news as opposed to bad news made it well oversold.Own due diligence.
onewayticket
04 Apr 2017
Re: Start of the bounce ? "Expect any bounce in sp with no news to be snuffed out by Darwin."It could alternatively be walked back up. That being where what are actual sells are shown as buys to bring the price back up. The sell price for instance being agreed in advance last week.Just be careful what you believe if trade watching.Strange things happen in marketsOwn due diligence.
onewayticket
04 Apr 2017
Re: Start of the bounce ? Good Luck .They all have a value point where they look cheap and people buy in.Own due diligence.
onewayticket
04 Apr 2017
Re: Start of the bounce ? Afternoon Disorder.£4.24M last night was far too cheap.Even £5Mill or £6Mill as a market cap is too cheap in my eyes and it would be double that or more but for Darwin. There are two potentially lucrative contracts that have been signed. Either one would change the landscape. Then add in patents, hq's etc and I'll bet the NAV is much higher. That is what ends up being the case with most Darwin situations as the market loses its bearings. They (Darwin) would shift more forward selling stock if they sell then stop and let the share price rise back up again to some semblance of normality. That said you can drop the price but it then starts to become appealing to many.I fully expect the share price to get back into the mid teens when they are clear. I'll have a look at advanced oncology at some point.Own due diligence.
Ewan Hoosami
04 Apr 2017
Re: Start of the bounce ? With shareholders' funds of minus £11m, cashburn of 100k a month and Darwin leaking shares onto the market, you could argue the marcap is about £4m too high.I'd expected an update on the second tranche of loan notes, due to be issued on 17 March, with yesterday's RNS. Assuming they were issued as planned, there are now 40 notes worth £1m still to convert. Expect any bounce in sp with no news to be snuffed out by Darwin.
Disorder
04 Apr 2017
Onewayticket. Start of the bounce?Have you ever taken an interest in AVO?Advanced Oncotherapy PLC.The directors and non exec directors pile their own cash into it like its going out of fashion.Way way to many bits to chat about, but the recent drop has been orchestrated due to the manner in which funding was executed.Shame really, because about a month ago a director was piling in at more than double and almost treble todays sp.2 directors have added today again.I know its off topic, but sure you wont mind if it rises just a quarter of what i am expecting it to.
Disorder
04 Apr 2017
Start of the bounce ? Expecting a bounce of some proportions.The 20% increase being shown could be the start?Onewayticket. Agree totally and unequivocally that the current MC is way way to low...Will likely wake up again at circa 6p.ZZZZZZZZZzzzzzzzzzzzzzzzzzzzzzzz
Disorder
04 Apr 2017
Re: Market Cap I think we all know a bounce will ensue..But when and from what point?I agree 100% @ £4.2 Million, it is effectively just way to cheap.
onewayticket
03 Apr 2017
Market Cap at £4.24million tonight.Looks a bit lowOwn due diligence
Disorder
03 Apr 2017
Re: Its an Interesting Watch You were spot on Ewan....Nice one...Graphene NanoChem PLC("Graphene NanoChem" or the "Group"
Conversion of loan note and issue of equity Graphene NanoChem plc. (AIM:GRPH), the international provider of nanotechnology performance enhancing solutions for global industries, announces that it has received a notice of exercise by Darwin Capital Limited ("Darwin" to convert 10 loan notes with an aggregate par value of £250,000 into equity ("Conversion Notice" in relation to the convertible loan note, as announced on 23 December 2016.The Conversion Notice was received in aggregate for £250,000 of the loan notes. The Company has therefore issued today 6,130,011 new ordinary shares to Darwin ("Darwin Shares" at an issue price of 4.078296p per Darwin Share. The Darwin Shares will rank pari passu in all respects with the existing ordinary shares. Application will be made for the Darwin Shares to be admitted to trading on AIM and admission is expected to take place on or around 7 April 2017. The Par Value outstanding on the remaining issued 10 loan notes is £250,000 after conversion today. Terms of the loan notes, including redemption and conversion, were set out in the announcement dated 23 December 2016.Following the issue of the Darwin Shares, the Company's issued share capital consists of 127,068,500 ordinary shares, with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
